Novartis AG (NVSN) — Cash Flow Reinvestment Rate
Novartis AG (NVSN) has a Cash Flow Reinvestment Rate of 0.52x as of March 2026, reinvesting MX$1.92 Billion (capex MX$807.00 Million plus investments MX$1.11 Billion) from operating cash flow of MX$3.68 Billion. Check NVSN cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Novartis AG Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Novartis AG across 12 annual periods. Explore investment intensity of Novartis AG to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Novartis AG (2014–2025)
Year-by-year capital reinvestment analysis for Novartis AG. For live market cap and broader valuation context, see Novartis AG market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (MXN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | MX$5.77 Billion | MX$19.14 Billion | MX$3.90 Billion | ▲ +37.4% |
| 2024 | 0.22x | MX$3.87 Billion | MX$17.62 Billion | MX$3.81 Billion | ▼ -60.0% |
| 2023 | 0.55x | MX$8.79 Billion | MX$16.02 Billion | MX$2.90 Billion | ▲ +33.5% |
| 2022 | 0.41x | MX$5.85 Billion | MX$14.24 Billion | MX$1.20 Billion | ▼ -24.4% |
| 2021 | 0.54x | MX$8.19 Billion | MX$15.07 Billion | MX$1.38 Billion | ▲ +237.8% |
| 2020 | 0.16x | MX$2.20 Billion | MX$13.65 Billion | MX$1.27 Billion | ▼ -51.9% |
| 2019 | 0.33x | MX$4.56 Billion | MX$13.62 Billion | MX$1.38 Billion | ▼ -60.6% |
| 2018 | 0.85x | MX$12.10 Billion | MX$14.27 Billion | MX$1.25 Billion | ▲ +690.9% |
| 2017 | 0.11x | MX$1.35 Billion | MX$12.62 Billion | MX$1.32 Billion | ▼ -80.5% |
| 2016 | 0.55x | MX$6.32 Billion | MX$11.47 Billion | MX$2.88 Billion | ▲ +134.2% |
| 2015 | 0.24x | MX$2.80 Billion | MX$11.90 Billion | MX$2.37 Billion | ▼ -46.4% |
| 2014 | 0.44x | MX$6.10 Billion | MX$13.90 Billion | MX$2.62 Billion | — |